Home > Alembic Pharmaceuticals

US FDA Approves Bronchoconstriction Drug of Alembic Pharmaceuticals

The Food and Drug Administration (FDA) of the United States has given the final approval to the Alembic Pharmaceuticals for the company’s Abbreviated New Drug Application (ANDA) for the Arformoterol Tartrate Inhalation Solution and because of this approval, the shares of the company has also increased. The approved ANDA of Alembic

Read More